Abstracts tagged "Familial Mediterrenean Fever"

Abstract Number: 1108 • ACR Convergence 2021
More Frequent, Earlier Hip Involvement and Poor Outcome in Spondyloarthritis Associated with Familial Mediterranean Fever
Murat Bektaş¹, Selma Sari², Cigdem Cetin³, Banu Cicek Yalcin Dulundu², Nevzat Koca², Burak Ince², Yasemin Yalcinkaya³, Bahar Esen³, Murat İnanç⁴, Lale Öcal⁴ and Ahmet Gül⁵, ¹Istanbul Faculty of Medicine, Istanbul, Turkey, ²Istanbul Faculty of Medicine, Istanbul University, Division of Rheumatology, İstanbul, Turkey, ³Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey, ⁴Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İstanbul, Turkey, ⁵Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey
Background/Purpose: Familial Mediterranean Fever (FMF), an autoinflammatory disease, is characterized by self-limited inflammatory attacks. A significant proportion of patients with FMF experience episodes of acute…
Abstract Number: 1111 • ACR Convergence 2021
Transient Elastography (fibroscan); As a New Non-invasive Diagnostic Method for Detecting Hepatic Involvement of Amyloidosis
Murat Bektaş¹, Bilger Çavuş², Besim Fazil Agargun³, Volkan Şenkal², Nevzat Koca⁴, Burak Ince⁴, Pelin Özer Karaca⁵, Metban Mestanzade⁶, Melek Büyük⁷, Melike Zehra Buğra⁵, Mine Güllüoğlu⁷, Sevgi Beşışık⁶, Yasemin Yalcinkaya⁸, Bahar Esen⁸, Murat İnanç⁹, Fatih Beşışık² and Ahmet Gül¹⁰, ¹Istanbul Faculty of Medicine, Istanbul, Turkey, ²Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology, İstanbul, Turkey, ³Istanbul Faculty of Medicine, Istanbul University, Department of Internal Medicine, İstanbul, Turkey, ⁴Istanbul Faculty of Medicine, Istanbul University, Division of Rheumatology, İstanbul, Turkey, ⁵Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology, İstanbul, Turkey, ⁶Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey, ⁷Istanbul University, Istanbul Faculty of Medicine, Department of Pathology, İstanbul, Turkey, ⁸Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey, ⁹Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İstanbul, Turkey, ¹⁰Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey
Background/Purpose: Amyloidosis is characterized by accumulation of insoluble fibrils composed of different monomers in extracellular spaces of different organs, and demonstration of deposits by non-invasive…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].